• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Parexel receives CEO Cancer Gold Standard re-accreditation

Parexel receives CEO Cancer Gold Standard re-accreditation

July 11, 2017
CenterWatch Staff

Parexel International, a global biopharmaceutical services provider, announced that the CEO Roundtable on Cancer has again named Parexel a CEO Cancer Gold Standard employer. The biennial U.S.-based accreditation, which Parexel previously received in 2015, recognizes the Company’s strong commitment to the health of its employees and their families.

The Gold Standard provides a framework for employers to have healthier workplaces by focusing on cancer risk education, early detection, access to clinical trials and high-quality care. To earn the accreditation, companies must demonstrate concrete efforts to address cancer in the workplace. Parexel has several programs in place to help its employees reduce cancer risk, including:

  • Promoting physical activity, healthy nutrition and weight management
  • Offering a medical incentive program to reduce an employee’s health plan contribution costs following completion of health and wellness activities
  • Providing health insurance options that include detection of cancer at its earliest stages, participation in cancer clinical trials and access to quality care
  • Supporting the needs of cancer survivors in the workplace
  • Prohibiting tobacco use and supporting cessation efforts

“At Parexel, our employees are the key to our success as we help our clients bring life-saving treatments to patients around the globe,” said Josef von Rickenbach, chairman and CEO, Parexel. “We are honored that the CEO Roundtable on Cancer has once again named us a Gold Standard employer for our continued commitment to the health and well-being of our employees and their families.”

The CEO Roundtable on Cancer is a nonprofit organization of CEOs founded in 2001, when former President George H.W. Bush challenged a group of executives to "do something bold and venturesome about cancer within your own corporate families." The CEOs responded by creating and encouraging the widespread adoption of the CEO Cancer Gold Standard™, which calls for organizations to evaluate their health benefits and workplace culture and take extensive, concrete actions in five key areas of health and wellness to address cancer in the workplace.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing